Effects of some benzodiazepine derivatives on fibrinolysis and serum lipids in normolipidaemic rats and in humans.
D000328:Adult; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D003009:Clorazepate Dipotassium / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008140:Lorazepam / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D051381:Rats; D014280:Triglycerides / Q000097:blood
D014151:Anti-Anxiety Agents; D008055:Lipids; D014280:Triglycerides; D003009:Clorazepate Dipotassium; D002707:Chlordiazepoxide; D002784:Cholesterol; D008140:Lorazepam; D003975:Diazepam